Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

ulcers

- PMLiVE

AstraZeneca’s baxdrostat shows promise in phase 3 hypertension study

Around 1.3 billion people globally are living with consistently high blood pressure levels

- PMLiVE

Getting to the Heart of the Matter: Medscape Education at AHA 2024!

Come join Medscape Education at the American Heart Association (AHA) 2024 Scientific Sessions in Chicago, IL, from November 16-18 — a dynamic event packed with cutting-edge cardiology education that you...

Medscape Education

- PMLiVE

Roche partners with Alnylam on hypertension therapy in deal worth up to $2.8bn

Zilebesiran is in phase 2 development to treat hypertension in patients with high-unmet needs

Barber shops provide a short cut to BP reduction

As well as a haircut, barbers can shave millimetres off men's blood pressure

Life Healthcare Communications

- PMLiVE

Bayer photo contest to raise awareness of blood clot

Public invited to submit photos that take their breath away

- PMLiVE

FDA panel votes against Actavis hypertension combo

Places a question mark over the combination of Bystolic and Diovan

- PMLiVE

This month in 1989: the creation of Bristol-Myers Squibb

The emergence of a company with a new focus on healthcare and research

- PMLiVE

This month in 1924: the birth of Sir James Black

The Scottish scientist behind major breakthroughs in the treatment of ulcers and hypertension

- PMLiVE

This month in 1876: Creation of Eli Lilly & Company

How a visit to the Good Samaritan Drugstore put an Indiana teenager on the road to pharma success

- PMLiVE

Takeda CEO admits to Blopress mis-marketing

Campaign used graph indicating drug was superior to Pfizer’s Norvasc

- PMLiVE

This month in 1884: How ‘friable’ pills changed medicine delivery

This month in 1884: Dr William Upjohn files key structural patent for revolutionary pill design

Novartis building

Novartis withdraws application for Ruvise approval in EU

Had submitted imatinib mesylate for use in hypertension

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links